271 related articles for article (PubMed ID: 25986911)
1. Role of therapeutic plasmapheresis in ANCA-associated vasculitis.
Walters G
Pediatr Nephrol; 2016 Feb; 31(2):217-25. PubMed ID: 25986911
[TBL] [Abstract][Full Text] [Related]
2. Plasma exchange in ANCA-associated vasculitis: the pro position.
Kronbichler A; Shin JI; Wang CS; Szpirt WM; Segelmark M; Tesar V
Nephrol Dial Transplant; 2021 Jan; 36(2):227-231. PubMed ID: 33374018
[TBL] [Abstract][Full Text] [Related]
3. Plasma exchange as an adjunctive therapy in anti-neutrophil cytoplasm antibody-associated vasculitis.
Gulati K; Pusey CD
Expert Rev Clin Immunol; 2023 Apr; 19(4):417-430. PubMed ID: 36860127
[TBL] [Abstract][Full Text] [Related]
4. Plasma exchange for the management of ANCA-associated vasculitis: the con position.
Specks U; Fussner LA; Cartin-Ceba R; Casal Moura M; Zand L; Fervenza FC
Nephrol Dial Transplant; 2021 Jan; 36(2):231-236. PubMed ID: 33374017
[TBL] [Abstract][Full Text] [Related]
5. The treatment of ANCA-associated rapidly-progressive glomerulonephritis and Goodpasture syndrome with therapeutic apheresis.
Apaydin S
Transfus Apher Sci; 2018 Feb; 57(1):8-12. PubMed ID: 29503131
[TBL] [Abstract][Full Text] [Related]
6. PEXIVAS: The End of Plasmapheresis for ANCA-Associated Vasculitis?
De Vriese AS; Fervenza FC
Clin J Am Soc Nephrol; 2021 Feb; 16(2):307-309. PubMed ID: 32963016
[No Abstract] [Full Text] [Related]
7. Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis.
Walsh M; Merkel PA; Peh CA; Szpirt WM; Puéchal X; Fujimoto S; Hawley CM; Khalidi N; Floßmann O; Wald R; Girard LP; Levin A; Gregorini G; Harper L; Clark WF; Pagnoux C; Specks U; Smyth L; Tesar V; Ito-Ihara T; de Zoysa JR; Szczeklik W; Flores-Suárez LF; Carette S; Guillevin L; Pusey CD; Casian AL; Brezina B; Mazzetti A; McAlear CA; Broadhurst E; Reidlinger D; Mehta S; Ives N; Jayne DRW;
N Engl J Med; 2020 Feb; 382(7):622-631. PubMed ID: 32053298
[TBL] [Abstract][Full Text] [Related]
8. Apheresis to treat systemic vasculitis.
Moussi-Frances J; Sallée M; Jourde-Chiche N
Joint Bone Spine; 2018 Mar; 85(2):177-183. PubMed ID: 28602810
[TBL] [Abstract][Full Text] [Related]
9. Double Filtration Plasmapheresis in the Treatment of Antineutrophil Cytoplasmic Autoantibody Associated Vasculitis With Severe Renal Failure: A Preliminary Study of 15 Patients.
Chen Y; Yang L; Li K; Liu Z; Gong D; Zhang H; Liu Z; Hu W
Ther Apher Dial; 2016 Apr; 20(2):183-8. PubMed ID: 26948291
[TBL] [Abstract][Full Text] [Related]
10. Clinical presentation and outcome of pediatric ANCA-associated glomerulonephritis.
Kouri AM; Andreoli SP
Pediatr Nephrol; 2017 Mar; 32(3):449-455. PubMed ID: 27677979
[TBL] [Abstract][Full Text] [Related]
11. Plasma exchange and glucocorticoid dosing for patients with ANCA-associated vasculitis: a clinical practice guideline.
Zeng L; Walsh M; Guyatt GH; Siemieniuk RAC; Collister D; Booth M; Brown P; Farrar L; Farrar M; Firth T; Fussner LA; Kilian K; Little MA; Mavrakanas TA; Mustafa RA; Piram M; Stamp LK; Xiao Y; Lytvyn L; Agoritsas T; Vandvik PO; Mahr A
BMJ; 2022 Feb; 376():e064597. PubMed ID: 35217581
[TBL] [Abstract][Full Text] [Related]
12. [PEXIVAS-The kiss of death for plasma exchange in ANCA-associated vasculitis?].
Löffler C; Hellmich B
Z Rheumatol; 2020 Nov; 79(9):910-911. PubMed ID: 33025026
[No Abstract] [Full Text] [Related]
13. Case report: de novo ANCA-associated vasculitis after kidney transplantation treated with rituximab and plasma exchange.
Sagmeister MS; Weiss M; Eichhorn P; Habicht A; Habersetzer R; Fischereder M; Schönermarck U
BMC Nephrol; 2018 Oct; 19(1):270. PubMed ID: 30340563
[TBL] [Abstract][Full Text] [Related]
14. Double Filtration Plasmapheresis in the Treatment of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis with Severe Kidney Dysfunction.
Cheng L; Tang YQ; Yi J; Ren Q; Yang XY; Gou SJ; Zhang L; Fu P
Blood Purif; 2020; 49(6):713-722. PubMed ID: 32294643
[TBL] [Abstract][Full Text] [Related]
15. Increase of Antimyeloperoxidase Antineutrophil Cytoplasmic Antibody (ANCA) in Patients with Renal ANCA-associated Vasculitis: Association with Risk to Relapse.
Yamaguchi M; Ando M; Kato S; Katsuno T; Kato N; Kosugi T; Sato W; Tsuboi N; Yasuda Y; Mizuno M; Ito Y; Matsuo S; Maruyama S
J Rheumatol; 2015 Oct; 42(10):1853-60. PubMed ID: 26373560
[TBL] [Abstract][Full Text] [Related]
16. Plasma exchange in antineutrophil cytoplasm antibody-associated vasculitis.
Walsh M
Curr Opin Nephrol Hypertens; 2014 Nov; 23(6):555-9. PubMed ID: 25144513
[TBL] [Abstract][Full Text] [Related]
17. A fatal case of propylthiouracil-induced ANCA-associated vasculitis resulting in rapidly progressive glomerulonephritis, acute hepatic failure, and cerebral angiitis.
Khan TA; Yin Luk FC; Uqdah HT; Arif A; Hussain H; Jayatilleke A; Aggarwal S
Clin Nephrol; 2015 May; 83(5):309-14. PubMed ID: 25208313
[TBL] [Abstract][Full Text] [Related]
18. The Fate of Plasma Exchange and Glucocorticoid Dosing in ANCA-Associated Vasculitis After PEXIVAS.
Cortazar FB; Niles JL
Am J Kidney Dis; 2020 Oct; 76(4):595-597. PubMed ID: 32277949
[No Abstract] [Full Text] [Related]
19. Effectiveness of plasmapheresis in ANCA clearance in patients with ANCA-associated vasculitides.
Górka J; Polok K; Nowak I; Włudarczyk A; Sydor W; Padjas A; Sznajd J; Szczeklik W; Musiał J
Przegl Lek; 2016; 73(7):445-7. PubMed ID: 29676884
[TBL] [Abstract][Full Text] [Related]
20. Treatment of severe renal disease in ANCA positive and negative small vessel vasculitis with rituximab.
Shah S; Hruskova Z; Segelmark M; Morgan MD; Hogan J; Lee SK; Dale J; Harper L; Tesar V; Jayne DR; Geetha D
Am J Nephrol; 2015; 41(4-5):296-301. PubMed ID: 26044574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]